controlled nitric oxide releasing patch

DRUG2 trials

Sponsors

Fundación Cardiovascular de Colombia

Conditions

Cutaneous LeishmaniasisDiabetic Foot

Phase 3

Controlled Nitric Oxide Releasing Patch Versus Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis

TerminatedNCT00317629

Fundación Cardiovascular de ColombiaCutaneous Leishmaniasis

Start: 2006-05-31End: 2009-03-31Updated: 2010-11-24

Clinical Trial for the Treatment of Diabetic Foot Ulcers Using a Nitric Oxide Releasing Patch: PATHON

CompletedNCT00428727

Fundación Cardiovascular de ColombiaDiabetic Foot

Start: 2005-01-31End: 2011-02-28Updated: 2012-11-06

Related Papers

Double blind, randomized, placebo controlled clinical trial for the treatment of diabetic foot ulcers, using a nitric oxide releasing patch: PATHON.

2007-09-2625 citations